Rare Cancer Aware

Our goal is to create meaningful public awareness about rare cancers and to support all those affected through education and dedicated support.

[SWOG Cancer Research Network @SWOG]

Our DART rare cancers trial, led by @PatelOncology @Dr_R_Kurzrock @youngkwangchae, is testing immunotherapies in 37 different rare cancer types. Learn more at https://t.co/QhBTj5C2Yq or call 1-800-4-CANCER https://t.co/fWDqG0bLRE

[Rare Cancer Aware @RareCancerAware]

Great example of local fundraising working with physicians to find ways to potentially improve care for a rare and aggressive type of cancer https://t.co/SiOn0eibG2

[CU Anschutz Cancer Center @CUCancerCenter]

Who would have known that ice cream is what funded research for new developments in treating anaplastic thyroid cancer? Learn more here:
https://t.co/N6HyJmpC5C

[Rare Cancer Aware @RareCancerAware]

@BingbingXLi That is great news! How far out is it from clinical trials?

[Rare Cancer Aware @RareCancerAware]

Alternative options for patients with GIST after imatinib. #GIST #rarecancer https://t.co/woz3ZvVC75

[JAMA Oncology @JAMAOnc]

Among patients with #imatinib-resistant #gastrointestinalstromaltumor (GIST), #dasatinib demonstrates evidence of activity and may be particularly effective in subset with phosphorylated SRC. Learn more https://t.co/Nonmdb0cR1 #sarcoma #GICSM

[Rare Cancer Aware @RareCancerAware]

@RareCancers @PressClubAust @PwC_AU @Qantas @Westpac So great!

[SWOG Cancer Research Network @SWOG]

Eligibility criteria is one of the hottest topics in cancer research, with @ASCO and @CancerResrch weighing in. @rschilsky will bring the conversation to @SWOG at our October meeting in Chicago. For now, see this great story in @statnews: https://t.co/SmM6AFOLfT

[Rare Cancers Australia @RareCancers]

We're trying to connect patients again, this time patients with Uterine Sarcoma or with T-cell Prolymphocytic Leukemia (T-PLL).

Please share and spread the word, #TeamRare, and if you or someone you know has either please get in touch. ❤️

[Rare Cancer Aware @RareCancerAware]

Rates of Merkel Cell carcinoma, a rare skin cancer, are on the rise. People on immunosuppression are at an increased risk. https://t.co/v8cUn7cVP2

[Rare Cancer Aware @RareCancerAware]

More research focused on treating metastatic cancer can lead to insurance actually approving treatments for people. Good stuff.
https://t.co/NkY1npzEa0

[Rare Cancer Aware @RareCancerAware]

Great people doing amazing things to support rare cancer research https://t.co/Pn4vRxfwtE

[Cycle for Survival @Cycle4Survival]

More than $30 million has been raised by the #CycleforSurvival community! The money you raise gives researchers and doctors at @sloan_kettering the power to advance rare cancer research. THANK YOU!

[Rare Cancer Aware @RareCancerAware]

Opportunity for combined immunotherapy treatment for people with rare cancers #immunotherapy #rarecancer https://t.co/zH1n84W0es

[SWOG Cancer Research Network @SWOG]

@_rarecancer @MicheleRhee @RareDiseaseDay @CheckOrphan @RareCancerAware @RareCancerRF Our @theNCI rare cancers trial offers immunotherapies. Learn more at https://t.co/QhBTj5C2Yq #RareDiseaseDay #ShowYourRare

[Rare Cancer Aware @RareCancerAware]

New treatment approved for gasteroenteropancreatic neuroendocrine tumors

https://t.co/pk7isSZh5J

[Rare Cancer Aware @RareCancerAware]

A new injection combining innate and adaptive immune system signaling, hopefully will play out well in human trials

https://t.co/vqcIQRLUMp

[Rare Cancer Aware @RareCancerAware]

Good job Australia! https://t.co/EQUzKrg2jI

[Rare Cancer Aware @RareCancerAware]

A health system offering free genomic testing to patients with rare or advanced cancer? Now there's a good idea

https://t.co/O72Ls9zZqe

[Rare Cancer Aware @RareCancerAware]

Overly restrictive eligibility criteria in many clinical trials frequently excludes the people who best represent the population the drug is intended for. #cancer
https://t.co/sXX18eG3Ew

[Rare Cancer Aware @RareCancerAware]

The bacteria in your gut can alter response to PD-1 #immunotherapy

https://t.co/Bc76Ujq654

[National Cancer Institute @theNCI]

Clinical trial aims to learn if adding #immunotherapy and vaccine to #glioblastoma therapy increases survival rate: https://t.co/6vZuwSbYLh

[Rare Cancer Aware @RareCancerAware]

Great #immunotherapy combo trial open to many types of rare cancers https://t.co/Gzt9tJMYx4

[Sandip Patel MD FASCO @PatelOncology]

Are there rare tumor slots available in a particular histology on DART?
The SWOG DART S1609 Accrual Dashboard by Histology: https://t.co/lsCNhpIp0s

#SWOG #Care4Rare #S1609 #DART

[Rare Cancer Aware @RareCancerAware]

Potential good combination for treating sarcoma https://t.co/Ts9BAEBKvC

[Sarcoma Alliance @SarcomaAlliance]

The combination of trabectedin (Yondelis) and nivolumab showed action against several types of sarcoma.... https://t.co/WXWxOClpHz